blog
English
  • All
  • Products
  • News
  • Manuals
  • Instruments
  • COVID-19/Influenza A+B Antigen Combo Rapid Test
    COVID-19/Influenza A+B Antigen Combo Rapid Test
    Intended Use

    The COVID-19/Influenza A+B Antigen Combo Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2, influenza A and influenza B viral nucleocapsid protein antigens in nasopharyngeal swab from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. Symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.

    Sample
    Nasopharyngeal Swab


    Contact Us
    Product Features
  • Easy handling, no instrument required.
  • Support the detection of nasopharyngeal swab.
  • Detection and differentiation of SARS-CoV-2, influenza A and influenza B viral nucleocapsid protein antigens.
  • Instant results at 15 minutes.
  • Results are clearly visible and reliable.
  • High sensitivity and specificity.
  • Excellent performance compared to molecular methods.
  • Product Information
    Catalog No.SpecificationsReaction TimeSensitivitySpecificityStorage ConditionShelf LifeCertification
    IrIDq325-B02525 tests/box15 mins

    For COVID-19 Antigen: 

    97.7% (95%CI: 93.5%~99.2%)


    For Influenza A: 

    89.0% (95%CI: 79.8%~94.3%)


    For Influenza B:

    84.7% (95%CI: 73.5%~91.8%)


    For COVID-19 Antigen: 

    99.8% (95%CI: 98.8%~100%)


    For Influenza A: 

    99.8% (95%CI: 99.0%~100%)


    For Influenza B: 

    99.6% (95%CI: 98.7%~99.9%)

    4-30℃24 monthsCE


    This product cannot be sold in the United States.

    Video
    Download
    Contact
    Thank you for the interest
    I agree that Clongene may use this information to contact me to assist with my request, I understand that all personal inforamtion I have submitted will be kept confidential in accordance with Clongene's privacy policy.